Parkman Healthcare Partners LLC historic quarter change: USA Stocks, Reduced
In share positions in stocks (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Parkman Healthcare Partners LLC opened 156 positions, added to 341, reduced 313 and sold out of 148.
- Q2 2026: Stock SYK; Country of operation United States; Class COM; Shares before 154,771.
- Q2 2026: Stock BSX; Country of operation United States; Class COM; Shares before 448,768.
- Q2 2026: Stock PODD; Country of operation United States; Class COM; Shares before 156,561.
- Q2 2026: Stock LIVN; Country of operation —; Class SHS; Shares before 403,965.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1777015), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2019-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2026 | SYK
STRYKER CORPORATION | United States | COM | 154,771 | 67,973 | -86,798 | $50,856,203 | $21,400,619 | -$29,455,584 | 2026-08-14 |
|---|
| Q2 2026 | BSX
BOSTON SCIENTIFIC CORP | United States | COM | 448,768 | 180,481 | -268,287 | $28,160,192 | $7,702,929 | -$20,457,263 | 2026-08-14 |
|---|
| Q2 2026 | PODD
INSULET CORP | United States | COM | 156,561 | 131,378 | -25,183 | $32,852,760 | $20,002,301 | -$12,850,459 | 2026-08-14 |
|---|
| Q2 2026 | LIVN
LIVANOVA PLC | | SHS | 403,965 | 210,529 | -193,436 | $25,676,015 | $17,311,800 | -$8,364,215 | 2026-08-14 |
|---|
| Q2 2026 | DXCM
DEXCOM INC | United States | COM | 689,822 | 534,767 | -155,055 | $43,320,822 | $36,016,557 | -$7,304,265 | 2026-08-14 |
|---|
| Q2 2026 | WAY
WAYSTAR HLDG CORP | United States | COM | 443,058 | 203,986 | -239,072 | $10,682,128 | $4,187,833 | -$6,494,295 | 2026-08-14 |
|---|
| Q2 2026 | AORT
ARTIVION INC | United States | COM | 252,014 | 138,940 | -113,074 | $9,228,753 | $3,121,982 | -$6,106,771 | 2026-08-14 |
|---|
| Q2 2026 | ATEC
ALPHATEC HLDGS INC | United States | COM NEW | 823,763 | 449,943 | -373,820 | $8,962,541 | $3,892,007 | -$5,070,534 | 2026-08-14 |
|---|
| Q2 2026 | XENE
XENON PHARMACEUTICALS INC | | COM | 497,035 | 397,379 | -99,656 | $28,902,585 | $23,985,796 | -$4,916,789 | 2026-08-14 |
|---|
| Q2 2026 | ANIP
ANI PHARMACEUTICALS INC | United States | COM | 280,575 | 202,907 | -77,668 | $21,576,218 | $16,796,641 | -$4,779,577 | 2026-08-14 |
|---|
| Q2 2026 | ABSI
ABSCI CORPORATION | United States | COM | 1,864,806 | 894,374 | -970,432 | $5,594,418 | $10,365,795 | +$4,771,377 | 2026-08-14 |
|---|
| Q2 2026 | ZBH
ZIMMER BIOMET HOLDINGS INC | United States | COM | 269,557 | 232,557 | -37,000 | $24,373,344 | $20,020,832 | -$4,352,512 | 2026-08-14 |
|---|
| Q2 2026 | NVST
ENVISTA HOLDINGS CORPORATION | United States | COM | 711,693 | 553,916 | -157,777 | $18,055,651 | $14,595,687 | -$3,459,964 | 2026-08-14 |
|---|
| Q2 2026 | ADPT
ADAPTIVE BIOTECHNOLOGIES COR | United States | COM | 551,815 | 486,984 | -64,831 | $7,659,192 | $10,445,807 | +$2,786,615 | 2026-08-14 |
|---|
| Q2 2026 | OPRX
OPTIMIZERX CORP | United States | COM NEW | 729,369 | 350,347 | -379,022 | $4,580,437 | $2,003,985 | -$2,576,452 | 2026-08-14 |
|---|
| Q2 2026 | RCUS
ARCUS BIOSCIENCES INC | United States | COM | 1,207,274 | 919,266 | -288,008 | $26,077,118 | $28,340,971 | +$2,263,853 | 2026-08-14 |
|---|
| Q2 2026 | SNDX
SYNDAX PHARMACEUTICALS INC | United States | COM | 901,511 | 877,256 | -24,255 | $21,059,297 | $19,176,816 | -$1,882,481 | 2026-08-14 |
|---|
| Q2 2026 | ERAS
ERASCA INC | United States | COM | 406,702 | 258,684 | -148,018 | $6,580,438 | $4,739,091 | -$1,841,347 | 2026-08-14 |
|---|
| Q2 2026 | AMLX
AMYLYX PHARMACEUTICALS INC | United States | COM | 621,458 | 398,782 | -222,676 | $8,638,266 | $7,162,125 | -$1,476,141 | 2026-08-14 |
|---|
| Q2 2026 | URGN
UROGEN PHARMA LTD | | COM | 275,000 | 174,064 | -100,936 | $4,944,500 | $6,405,555 | +$1,461,055 | 2026-08-14 |
|---|
| Q2 2026 | MMED
MINIMED GROUP INC | United States | COM | 317,324 | 226,446 | -90,878 | $4,734,474 | $3,385,368 | -$1,349,106 | 2026-08-14 |
|---|
| Q2 2026 | EYPT
EYEPOINT INC | United States | COM NEW | 1,354,800 | 1,288,163 | -66,637 | $17,463,372 | $18,420,731 | +$957,359 | 2026-08-14 |
|---|
| Q2 2026 | CDNA
CAREDX INC | United States | COM | 291,378 | 202,417 | -88,961 | $5,058,322 | $5,768,885 | +$710,563 | 2026-08-14 |
|---|
| Q2 2026 | SIBN
SI BONE INC | United States | COM | 373,553 | 328,686 | -44,867 | $4,717,974 | $5,364,156 | +$646,182 | 2026-08-14 |
|---|
| Q2 2026 | VIR
VIR BIOTECHNOLOGY INC | United States | COM | 500,000 | 475,279 | -24,721 | $4,480,000 | $4,843,093 | +$363,093 | 2026-08-14 |
|---|
| Q2 2026 | ENTX
ENTERA BIO LTD | | SHS | 288,670 | 274,497 | -14,173 | $320,424 | $485,860 | +$165,436 | 2026-08-14 |
|---|
| Q2 2026 | LUNG
PULMONX CORP | United States | COM | 755,636 | 646,564 | -109,072 | $974,770 | $840,533 | -$134,237 | 2026-08-14 |
|---|
| Q2 2026 | ANNX
ANNEXON INC | United States | COM | 674,013 | 641,029 | -32,984 | $3,734,032 | $3,660,276 | -$73,756 | 2026-08-14 |
|---|
| Q2 2026 | OVID
OVID THERAPEUTICS INC | United States | COM | 208,205 | 197,947 | -10,258 | $462,215 | $532,477 | +$70,262 | 2026-08-14 |
|---|
| Q2 2026 | BCRX
BIOCRYST PHARMACEUTICALS INC | United States | COM | 1,708,099 | 1,624,279 | -83,820 | $16,261,102 | $16,242,790 | -$18,312 | 2026-08-14 |
|---|